These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32738423)
1. Impact of prior authorizations on dermatology patients: A cross-sectional analysis. Guo LN; Nambudiri VE J Am Acad Dermatol; 2021 Jul; 85(1):217-220. PubMed ID: 32738423 [No Abstract] [Full Text] [Related]
2. Evaluating the effect of prior authorizations in patients with complex dermatologic conditions. Jew OS; Okawa J; Barbieri JS; McCaffrey J; Hayward E; Werth VP J Am Acad Dermatol; 2020 Dec; 83(6):1674-1680. PubMed ID: 32622138 [TBL] [Abstract][Full Text] [Related]
3. Administrative Burden and Costs of Prior Authorizations in a Dermatology Department. Carlisle RP; Flint ND; Hopkins ZH; Eliason MJ; Duffin KC; Secrest AM JAMA Dermatol; 2020 Oct; 156(10):1074-1078. PubMed ID: 32845288 [TBL] [Abstract][Full Text] [Related]
4. Dermatology in the emergency department: Prescriptions, rates of inpatient admission, and predictors of high utilization in the United States from 1996 to 2012. Yang JJ; Maloney NJ; Bach DQ; Cheng K J Am Acad Dermatol; 2021 May; 84(5):1480-1483. PubMed ID: 32687969 [No Abstract] [Full Text] [Related]
5. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review. Popatia S; Flood KS; Golbari NM; Patel PV; Olbricht SM; Kimball AB; Porter ML J Am Acad Dermatol; 2019 Dec; 81(6):1308-1318. PubMed ID: 31103568 [TBL] [Abstract][Full Text] [Related]
6. Impacts of COVID-19 on Dermatologic Practice, Disease Presentation, and Immunomodulator Prescriptions. Leis M; Fleming P; Lynde CW J Cutan Med Surg; 2021; 25(1):106-108. PubMed ID: 32936028 [No Abstract] [Full Text] [Related]
7. Advanced Therapy Treatment for Psoriasis: A Single-Site Retrospective Study of Prescribing Outcomes. Kim C; Joerg L; Levitt J Skinmed; 2017; 15(6):493-495. PubMed ID: 29282198 [No Abstract] [Full Text] [Related]
8. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population. Adamson AS; Suarez EA; Gorman AR JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045 [TBL] [Abstract][Full Text] [Related]
9. Prescribing trends for biologic drugs among Ohio dermatologists. Iacullo J; Kunzler E; Ezaldein HH; Scott JF Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261565 [TBL] [Abstract][Full Text] [Related]
10. Polypharmacy in dermatology: analysis of a nationally representative sample of 46,273 dermatology patient visits in the United States from 1995 to 2009. Gupta MA; Gupta AK; Fink NH Skinmed; 2013; 11(5):273-80. PubMed ID: 24340466 [TBL] [Abstract][Full Text] [Related]
11. What's new in dermatologic therapy. Thiers BH Dermatol Ther; 2008; 21(2):142-9. PubMed ID: 18394088 [TBL] [Abstract][Full Text] [Related]
13. The Practice of Dermatology Ain't What It Used To Be: The Preauthorization Catastrophe. Parish LC; Parish JL; Lambert WC; Ciferni C Skinmed; 2019; 17(3):152-153. PubMed ID: 31496468 [No Abstract] [Full Text] [Related]
14. American Academy of Dermatology Annual Meeting: Washington, DC, USA, 1-5 March 2019. Fraser KA Am J Clin Dermatol; 2019 Apr; 20(2):307-310. PubMed ID: 30888668 [No Abstract] [Full Text] [Related]
15. [Use of methotrexate in pediatric dermatology]. Mazereeuw-Hautier J; Uthurriague C Ann Dermatol Venereol; 2016 Feb; 143(2):154-61. PubMed ID: 26724843 [No Abstract] [Full Text] [Related]